Trial · NCT01682811
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Part 1: Photosensitizer Uptake and Conversion to Protoporphyrin IX | Part 1 Levulan Painted Twice Treated Lesions With Microneedling | 304 | Standard Deviation 94 | Densitometry units/micrometer squared | |
| Part 2: Maximum Tolerated Dose (MTD) of 633 nm Red Light | All Participants | 100 | joules/cm squared | ||
| Part 1: Optimal Occlusion Time | Part 1 Levulan Injection Control Lesions | NA | hours | ||
| Part 1: Optimal Occlusion Time | Part 1 Levulan Injection Treated Lesions 3 Hours | NA | hours | ||
| Part 1: Optimal Occlusion Time | Part 1 Levulan Injection Treated Lesions 24 Hours | NA | hours | ||
| Part 1: Optimal Occlusion Time | Part 1 Levulan Paint Control Lesions | NA | hours | ||
| Part 1: Optimal Occlusion Time | Part 1 Levulan Paint Treated Lesions 3 Hours | NA | hours | ||
| Part 1: Optimal Occlusion Time | Part 1 Levulan Paint Treated Lesions 24 Hours | NA | hours | ||
| Part 2: Efficacy - Lesion Area Growth Rate | Part 2 Dose Level 1 50 J/cm^2 Control | 0.212 | Standard Deviation 0.364 | millimeter squared/day post-treatment | |
| Part 2: Efficacy - Lesion Area Growth Rate | Part 2 Dose Level 1 50 J/cm^2 Treated | 0.081 | Standard Deviation 0.176 | millimeter squared/day post-treatment | |
| TUNEL Assay. | Part 2 Dose Level 1 50 J/cm^2 Control | 42.5 | Standard Deviation 19.9 | apoptotic cells/visual field | |
| TUNEL Assay. | Part 2 Dose Level 1 50 J/cm^2 Treated | 1.1 | Standard Deviation 1.4 | apoptotic cells/visual field |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01682811/results